WENDY KOOPMAN: Open Payments
NPI 1891728069 · GRAND RAPIDS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,987 in 85 payments from 40 companies in 2025. Trend: 2023 $533 · 2024 $1,488 · 2025 $1,987
Food & beverage: $1,892Education: $95
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 3 | $128 |
| Novartis Pharmaceuticals Corporation | 5 | $121 |
| JAZZ PHARMACEUTICALS INC. | 5 | $116 |
| SEAGEN INC. | 1 | $95 |
| Caris MPI, Inc. | 3 | $90 |
| Genentech USA, Inc. | 4 | $88 |
| PFIZER INC. | 7 | $87 |
| GENZYME CORPORATION | 4 | $80 |
| Regeneron Healthcare Solutions, Inc. | 3 | $79 |
| Syndax Pharmaceuticals, Inc. | 4 | $73 |
Products named: TECVAYLI, Fabhalta, ZEPZELCA, MI CANCER SEEK, SARCLISA, OPDIVO, VERZENIO, Trodelvy.
Industry payments across MI — which companies pay providers there.
